UniQure Gross Profit 2013-2022 | QURE

UniQure gross profit from 2013 to 2022. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
UniQure Annual Gross Profit
(Millions of US $)
2021 $524
2020 $38
2019 $7
2018 $11
2017 $13
2016 $25
2015 $11
2014 $6
2013 $3
2012 $
UniQure Quarterly Gross Profit
(Millions of US $)
2022-03-31 $2
2021-12-31 $58
2021-09-30 $2
2021-06-30 $441
2021-03-31 $0
2020-12-31 $34
2020-09-30 $2
2020-06-30 $2
2020-03-31 $0
2019-12-31 $3
2019-09-30 $1
2019-06-30 $2
2019-03-31 $1
2018-12-31 $2
2018-09-30 $3
2018-06-30 $3
2018-03-31 $3
2017-12-31 $3
2017-09-30 $2
2017-06-30 $5
2017-03-31 $3
2016-12-31 $9
2016-09-30 $7
2016-06-30 $4
2016-03-31 $4
2015-12-31 $4
2015-09-30 $3
2015-06-30 $2
2015-03-31 $1
2014-12-31 $2
2014-09-30 $1
2014-06-30 $1
2014-03-31 $2
2013-12-31
2013-09-30
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.640B $0.524B
UNIQURE B.V. is involved in developing gene therapy for patients of genetic or acquired diseases. It offers Glybera for the treatment of lipoprotein lipase deficiency, an orphan metabolic disease. The company's product pipeline includes which are in clinical trials are additional adeno-associated virus consist of AMT-060, AMT-021, AMT-110 and AAV2/glial. UNIQURE B.V. is headquartered in Amsterdam, the Netherlands.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $162.213B 9.87
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.280B 16.23
Biohaven Pharmaceutical Holding (BHVN) United States $10.017B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.593B 0.00
Emergent Biosolutions (EBS) United States $1.775B 7.60
Arcus Biosciences (RCUS) United States $1.357B 34.40
Myovant Sciences (MYOV) United Kingdom $1.000B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.486B 0.00
Gelesis Holdings (GLS) United States $0.360B 0.00
Zymeworks (ZYME) Canada $0.346B 0.00
Ambrx Biopharma (AMAM) United States $0.149B 0.00
Enzo Biochem (ENZ) United States $0.116B 23.80
SQZ Biotechnologies (SQZ) United States $0.099B 0.00